Max is acetylated by p300 at several nuclear localization residues

Biochemical Journal

Volumn 403, Issue 3, 2007, Pages 397-407

  Faiola, Francesco ^a   Wu, Yi Ting ^a   Pan, Songqin ^b   Zhang, Kangling ^b   Farina, Anthony ^a   Martinez, Ernest ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Histone acetyltransferase; Max; MS; Myc; Nuclear localization; p300

Indexed keywords

ACETYLATION; BINDING SITES; CELL GROWTH; CELL PROLIFERATION; DIMERIZATION; DNA; ENZYME KINETICS; MICROORGANISMS;

CELL DIFFERENTIATION; DNA BINDING; HISTONE ACETYLTRANSFERASE; METAZOANS; NUCLEAR LOCALIZATION;

TRANSCRIPTION FACTORS;

HELIX LOOP HELIX PROTEIN; HISTONE ACETYLTRANSFERASE GCN5; HISTONE DEACETYLASE; LEUCINE ZIPPER PROTEIN; MAX PROTEIN; ONCOPROTEIN; PROTEIN P300; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; CELL CYCLE PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; KARYOPHERIN ALPHA; LYSINE; MAX PROTEIN, HUMAN; P300-CBP-ASSOCIATED FACTOR; UNCLASSIFIED DRUG;

ACETYLATION; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DIMERIZATION; DNA BINDING; GENE LOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VITRO STUDY; NONHUMAN; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; WESTERN BLOTTING; GENETIC TRANSFECTION; HELA CELL; METABOLISM; NUCLEAR LOCALIZATION SIGNAL; PHYSIOLOGY; TANDEM MASS SPECTROMETRY;

MAMMALIA; METAZOA;

ACETYLATION; ALPHA KARYOPHERINS; AMINO ACID SEQUENCE; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL CYCLE PROTEINS; HELA CELLS; HISTONE ACETYLTRANSFERASES; HUMANS; LYSINE; NUCLEAR LOCALIZATION SIGNALS; TANDEM MASS SPECTROMETRY; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 34247868827     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20061593     Document Type: Article

References (59)

1. Grandori, C., Cowley, S. M., James, L. P. and Eisenman, R. N. (2000) The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653-699
2. Blackwood, E. M. and Eisenman, R. N. (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251, 1211-1217
3. Prendergast, G. C., Lawe, D. and Ziff, E. B. (1991) Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 65, 395-407
4. Amati, B., Dalton, S., Brooks, M. W., Littlewood, T. D., Evan, G. I. and Land, H. (1992) Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359, 423-426
5. Amati, B., Brooks, M. W., Levy, N., Littlewood, T. D., Evan, G. I. and Land, H. (1993) Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72, 233-245
6. Kato, G. J., Lee, W. M., Chen, L. L. and Dang, C. V. (1992) Max: functional domains and interaction with c-Myc. Genes Dev. 6, 81-92
7. Ayer, D. E., Kretzner, L. and Eisenman, R. N. (1993) Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72, 211-222
8. Zervos, A. S., Gyuris, J. and Brent, R. (1993) Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72, 223-232
9. Hurlin, P. J., Queva, C., Koskinen, P. J., Steingrimsson, E., Ayer, D. E., Copeland, N. G., Jenkins, N. A. and Eisenman, R. N. (1995) Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 14, 5646-5659
10. Hurlin, P. J., Queva, C. and Eisenman, R. N. (1997) Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev. 11, 44-58
11. Meroni, G., Reymond, A., Alcalay, M., Borsani, G., Tanigami, A., Tonlorenzi, R., Nigro, C. L., Messali, S., Zollo, M., Ledbetter, D. H. et al. (1997) Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J. 16, 2892-2906
12. Hurlin, P. J., Steingrimsson, E., Copeland, N. G., Jenkins, N. A. and Eisenman, R. N. (1999) Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. EMBO J. 18, 7019-7028
13. Luo, X. and Sawadogo, M. (1996) Antiproliferative properties of the USF family of helix-loop-helix transcription factors. Proc. Natl. Acad. Sci. U.S.A. 93, 1308-1313
14. Boyd, K. E. and Farnham, P. J. (1999) Coexamination of site-specific transcription factor binding and promoter activity in living cells. Mol. Cell. Biol. 19, 8393-8399
15. Lee, T. C. and Ziff, E. B. (1999) Mxi1 is a repressor of the c-Myc promoter and reverses activation by USF. J. Biol. Chem. 274, 595-606
16. McMurray, H. R. and McCance, D. J. (2003) Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression. J. Virol. 77, 9852-9861
17. Choe, C., Chen, N. and Sawadogo, M. (2005) Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2. Exp. Cell Res. 302, 1-10
18. McMahon, S. B., Wood, M. A. and Cole, M. D. (2000) The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol. Cell. Biol. 20, 556-562
19. Park, J., Kunjibettu, S., McMahon, S. B. and Cole, M. D. (2001) The ATM-related domain of TRRAP is required for histone acetyltransferase recruitment and Myc-dependent oncogenesis. Genes Dev. 15, 1619-1624
20. Bouchard, C., Dittrich, O., Kiermaier, A., Dohmann, K., Menke, A., Eilers, M. and Luscher, B. (2001) Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev. 15, 2042-2047
21. Amati, B., Frank, S. R., Donjerkovic, O. and Taubert, S. (2001) Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim. Biophys. Acta 1471, M135-M145
22. Luscher, B. (2001) Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene 277, 1-14
23. Liu, X., Testai, J., Evrard, Y. A., Dent, S. Y. and Martinez, E. (2003) c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation. J. Biol. Chem. 278, 20405-20412
24. Frank, S. R., Parisi, T., Taubert, S., Fernandez, P., Fuchs, M., Chan, H. M., Livingston, D. M. and Amati, B. (2003) MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep. 4, 575-580
25. Ayer, D. E., Lawrence, Q. A. and Eisenman, R. N. (1995) Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80, 767-776
26. Schreiber-Agus, N., Chin, L., Chen, K., Torres, R., Rao, G., Guida, P., Skoultchi, A. I. and DePinho, R. A. (1995) An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80, 777-786
27. Laherty, C. D., Yang, W. M., Sun, J. M., Davie, J. R., Seto, E. and Eisenman, R. N. (1997) Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89, 349-356
28. Hassig, C. A., Fleischer, T. C., Billin, A. N., Schreiber, S. L. and Ayer, D. E. (1997) Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89, 341-347
29. Alland, L., Muhle, R., Hou, Jr, H., Potes, J., Chin, L., Schreiber-Agus, N. and DePinho, R. A. (1997) Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387, 49-55
30. Kretzner, L., Blackwood, E. M. and Eisenman, R. N. (1992) Myc and Max proteins possess distinct transcriptional activities. Nature 359, 426-429
31. Makela, T. P., Koskinen, P. J., Vastrik, I. and Alitalo, K. (1992) Alternative forms of Max as enhancers or suppressors of Myc-ras cotransformation. Science 256, 373-377
32. Mukherjee, B., Morgenbesser, S. D. and DePinho, R. A. (1992) Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. Genes Dev. 6, 1480-1492
33. Prendergast, G. C., Hopewell, R., Gorham, B. J. and Ziff, E. B. (1992) Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions. Genes Dev. 6, 2429-2439
34. Reddy, C. D., Dasgupta, P., Saikumar, P., Dudek, H., Rauscher, III, F. J. and Reddy, E. P. (1992) Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation. Oncogene 7, 2085-2092
35. Gu, W., Cechova, K., Tassi, V. and Dalla-Favera, R. (1993) Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc. Natl. Acad. Sci. U.S.A. 90, 2935-2939
36. Amin, C., Wagner, A. J. and Hay, N. (1993) Sequence-specific transcriptional activation by Myc and repression by Max. Mol. Cell. Biol. 13, 383-390
37. Vastrik, I., Makela, T. P., Koskinen, P. J. and Alitalo, K. (1995) Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max. Oncogene 11, 553-560
38. Krippner-Heidenreich, A., Talanian, R. V., Sekul, R., Kraft, R., Thole, H., Ottleben, H. and Luscher, B. (2001) Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1. Biochem. J. 358, 705-715
39. Facchini, L. M. and Penn, L. Z. (1998) The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12, 633-651
40. Huang, Z. (2004) Stress signaling and Myc downregulation: implications for cancer. Cell Cycle 3, 593-596
41. Kamemura, K., Hayes, B. K., Comer, F. I. and Hart, G. W. (2002) Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. J. Biol. Chem. 277, 19229-19235
42. Amati, B. (2004) Myc degradation: dancing with ubiquitin ligases. Proc. Natl. Acad. Sci. U.S.A. 101, 8843-8844
43. Vervoorts, J., Luscher-Firzlaff, J. M., Rottmann, S., Lilischkis, R., Walsemann, G., Dohmann, K., Austen, M. and Luscher, B. (2003) Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 4, 484-490
44. Patel, J. H., Du, Y., Ard, P. G., Phillips, C., Carella, B., Chen, C. J., Rakowski, C., Chatterjee, C., Lieberman, P. M., Lane, W. S. et al. (2004) The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol. Cell. Biol. 24, 10826-10834
45. Zhang, K., Faiola, F. and Martinez, E. (2005) Six lysine residues on c-Myc are direct substrates for acetylation by p300. Biochem. Biophys. Res. Commun. 336, 274-280
46. Faiola, F., Liu, X., Lo, S., Pan, S., Zhang, K., Lymar, E., Farina, A. and Martinez, E. (2005) Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription. Mol. Cell. Biol. 25, 10220-10234
47. Wenzel, A., Cziepluch, C., Hamann, U., Schurmann, J. and Schwab, M. (1991) The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells. EMBO J. 10, 3703-3712
48. Berberich, S. J. and Cole, M. D. (1992) Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers. Genes Dev. 6, 166-176
49. Bousset, K., Henriksson, M., Luscher-Firzlaff, J. M., Litchfield, D. W. and Luscher, B. (1993) Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers. Oncogene 8, 3211-3220
50. 2-terminal sites. Cell Growth Differ. 5, 313-320
51. Walhout, A. J., Gubbels, J. M., Bernards, R., van der Vliet, P. C. and Timmers, H. T. M. (1997) c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene. Nucleic Acids Res. 25, 1493-1501
52. Currie, R. A. (1998) NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF. J. Biol. Chem. 273, 1430-1434
53. Ogryzko, V. V., Schlitz, R. L., Russanova, V., Howard, B. H. and Nakatani, Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959
54. McMahon, S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D. and Cole, M. D. (1998) The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94, 363-374
55. Farina, A., Faiola, F. and Martinez, E. (2004) Reconstitution of an E box-binding Myc:Max complex with recombinant full-length proteins expressed in Escherichia coli. Protein Expression Purif. 34, 215-222
56. Grinberg, A. V., Hu, C. D. and Kerppola, T. K. (2004) Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells. Mol. Cell. Biol. 24, 4294-4308
57. Ferre-D'Amare, A. R., Prendergast, G. C., Ziff, E. B. and Burley, S. K. (1993) Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature 363, 38-45
58. Brownlie, P., Ceska, T., Lamers, M., Romier, C., Stier, G., Teo, H. and Suck, D. (1997) The crystal structure of an intact human Max-DNA complex: new insights into mechanisms of transcriptional control. Structure 5, 509-520
59. Nair, S. K. and Burley, S. K. (2003) X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors. Cell 112, 193-205